Effect of cytostatics on bone marrow stem cells

Area of Science:

• Hematology
• Oncology
• Stem Cell Biology

Background:

• Chemotherapy agents like adriamycin, cyclophosphamide, and 5-fluorouracil are known to cause myelosuppression.
• Understanding the differential effects of these agents on bone marrow components is crucial for managing treatment side effects and developing supportive therapies.

Purpose of the Study:

• To investigate the impact of three common cytostatic drugs on the bone marrow's morphological composition.
• To analyze the content and proliferative/differentiative capacity of hematopoietic precursors.
• To assess the size and response of the mesenchymal stem cell pool to cytostatic-induced myelosuppression.

Main Methods:

• Experiments were conducted on CBA/CaLac mice.
• Myelosuppression was induced using maximum tolerated doses of adriamycin, cyclophosphamide, and 5-fluorouracil.
• Bone marrow morphology, hematopoietic precursor content, proliferation, differentiation, and mesenchymal precursor pool size were analyzed.

Main Results:

• The dynamics of granulomonocyte and erythroid precursor changes in bone marrow post-cytostatic treatment were similar.
• Alterations in stromal mechanocyte content exhibited specificity depending on the cytostatic drug used.
• Hemopoietic and mesenchymal stem cells demonstrated distinct responses to the tested cytostatic agents.

Conclusions:

• Cytostatic drugs induce myelosuppression with varying effects on bone marrow components.
• While hematopoietic precursor dynamics show similarities, mesenchymal stromal cells respond distinctively to different chemotherapeutics.
• Hemopoietic and mesenchymal stem cell populations exhibit differential sensitivity to cytostatic-induced stress.